Patient Compliance

There’s no better time than now to update Canada’s health system with a national pharmaceutical program

Have you ever watched a television commercial or seen a magazine advertisement for a nonprescription medication that claims to be pharmacists’ most-recommended brand?

New CAG guidelines update the 2004 guidelines that addressed the use of infliximab in Crohn's disease.